デフォルト表紙
市場調査レポート
商品コード
1485875

細胞株特性評価市場:細胞株タイプ別、用途別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Cell Line Characterization Market, By Cell Line Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 247 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
細胞株特性評価市場:細胞株タイプ別、用途別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年05月04日
発行: AnalystView Market Insights
ページ情報: 英文 247 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

細胞株特性評価市場規模は2023年に3億8,120万米ドルとなり、2024年から2032年にかけてCAGR 8.00%で拡大

細胞株特性評価市場-市場力学

バイオテクノロジーと医薬品分野における研究開発の増加が細胞株特性評価市場の成長を促進

細胞株特性評価の利用は、さまざまな慢性疾患の治療に対するニーズの高まりに対応するため、バイオテクノロジーおよび製薬産業における研究開発が活発化した結果、発展しつつあります。細胞がウイルスや細菌などの感染因子とどのように相互作用するかをよりよく理解するために、研究者は細胞化学と生物学の研究で細胞をモデル系として採用しています。薬剤がヒト細胞にどのような影響を与えるかを調べるために、細胞は薬剤スクリーニングにも用いられています。医学研究への資金提供の増加が、細胞株特性評価市場の成長を後押ししています。バイオテクノロジーや製薬業界における研究開発の活発化も、自動細胞培養装置の開発に寄与しています。細胞株特性評価事業は、この画期的な進歩によって推進されると予想されます。今後数年間で、これは製薬・バイオ医薬品産業の拡大につながり、細胞株特性評価の世界市場を押し上げると思われます。製薬、バイオテクノロジー、その他のヘルスケア企業は研究開発費を増やしており、これが市場拡大の原動力となっています。

細胞株特性評価市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界の細胞株特性評価市場は予測期間(2024-2032年)に約8.00%のCAGRで毎年成長すると予測されています。

用途別では、細胞株同定セグメントは2023年に最大市場シェアを示すと予測されました。

エンドユーザー別では、学術研究機関セグメントが最も速い成長を示すと予測されています。

地域別では、北米が2023年に主要な収益源となった。

細胞株特性評価市場-セグメンテーション分析:

世界の細胞株特性評価市場は、細胞株タイプ、用途、エンドユーザー、地域に基づいて区分されます。

市場は細胞株タイプに基づいて2つのカテゴリーに分けられる:哺乳類、微生物、昆虫細胞です。2023年には、哺乳類カテゴリーが主に市場をリードしました。哺乳類細胞株の形成は、遺伝子とタンパク質の相互作用や発生生物学の研究に基づいています。哺乳類細胞株は、生物学的成分やヒト組織への適応が容易であり、感染リスクも低いことから、予測期間中、市場拡大の原動力となると思われます。

さらに、市場は用途に基づいて4つのカテゴリーに区分される:細胞株の同一性、遺伝的安定性、ウイルス・微生物汚染、その他です。2023年、市場内で支配的なセグメントは細胞株同一性カテゴリーです。バイオ医薬品の研究と製造では、規制当局が細胞株の認証とバリデーションに関する基準を厳格化するにつれて、細胞株の同一性の正確性と信頼性を保証することがますます重視されるようになっています。クロスコンタミネーション、誤同定、遺伝子ドリフトといった、研究結果、薬剤の有効性、患者の安全性を危うくする危険性を低減したいという願いから、細胞株の同一性確認が重視されるようになっています。

細胞株特性評価市場-地理的洞察

細胞株特性評価市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカといった地域ごとに地理的な多様性を示しており、それぞれが独自の特徴を有しています。北米は成熟市場であり、強力なバイオ医薬品部門と広大な研究ネットワークにより高い需要があります。さらに、技術開発、バイオ医薬品市場の立ち上がり、細胞ベースの治療・研究用途の拡大などが、市場を成長させると予想される要素です。

さらに、アジア太平洋市場は、ヘルスケア・インフラの建設が重視され、バイオ医薬品の生産能力が高まっていることから、予測期間中に成長すると予測されています。さらに、この地域は、バイオテクノロジーや製薬分野への投資の拡大、ヘルスケアインフラの整備、オーダーメイド医療に対する意識の高まりなどの要因によって成長しています。

細胞株特性評価市場-競合情勢:

Premas Biotechare、Thermo Fisher Scientific Inc.、WuXi Biologics Cayman Inc.、Promega Corp.、DNA TwoPointO Inc.などは、同市場における著名企業の一例です。これらの企業は、最先端の製品とソリューションを顧客に提供するために、複数のM&Aや合弁事業を行っています。製品能力を向上させ、細胞株特性評価分野での市場競争力を維持するため、これらの市場企業は様々な成長戦略、提携、発売、合併、買収を実践しています。

目次

第1章 細胞株特性評価市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 細胞株の特性評価主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 細胞株特性評価業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 細胞株特性評価市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 細胞株特性評価市場情勢

  • 細胞株特性評価市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 細胞株特性評価市場- 細胞株タイプ別

  • 概要
    • 細胞株タイプ別セグメントシェア分析
    • 哺乳類
    • 微生物
    • 昆虫細胞

第8章 細胞株特性評価市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 細胞株のアイデンティティ
    • 遺伝的安定性
    • ウイルスおよび微生物汚染
    • その他

第9章 細胞株特性評価市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • 学術調査機関
    • その他

第10章 細胞株特性評価市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 細胞株特性評価業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Boehringer Ingelheim International GmbH
    • JSR Corp.
    • Premas Biotech
    • Danaher Corp.
    • DNA TwoPointO Inc.
    • MabPlex International Ltd.
    • Sartorius AG
    • Lonza Group Ltd.
    • Thermo Fisher Scientific Inc.
    • WuXi Biologics Cayman Inc.
    • Promega Corp.
    • General Electric Co.
    • Corning Inc.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cell Line Characterization Market: Cell Line Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Line Type
  • TABLE Global Cell Line Characterization Market, by Cell Line Type 2019-2032 (USD Million)
  • TABLE Cell Line Characterization Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cell Line Characterization Market, by Application 2019-2032 (USD Million)
  • TABLE Cell Line Characterization Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Cell Line Characterization Market, by End User 2019-2032 (USD Million)
  • TABLE Cell Line Characterization Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cell Line Characterization Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cell Line Characterization Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cell Line Characterization Market, by Cell Line Type, 2019-2032 (USD Million)
  • TABLE North America Cell Line Characterization Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Cell Line Characterization Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Cell Line Characterization Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cell Line Characterization Market, by Cell Line Type, 2019-2032 (USD Million)
  • TABLE Europe Cell Line Characterization Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Cell Line Characterization Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Line Characterization Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Line Characterization Market, by Cell Line Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Line Characterization Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Line Characterization Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Cell Line Characterization Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cell Line Characterization Market, by Cell Line Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell Line Characterization Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Cell Line Characterization Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Line Characterization Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Line Characterization Market, by Cell Line Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Line Characterization Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Line Characterization Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2779

REPORT HIGHLIGHT

Cell Line Characterization Market size was valued at USD 381.2 Million in 2023, expanding at a CAGR of 8.00% from 2024 to 2032.

In several fields of biomedical exploration, such as drug development, toxicity testing, and the investigation of disease causes, cell line characterization is an important step. Additionally, cell lines are used in the production of biopharmaceuticals such as monoclonal antibodies and vaccinations. Additionally, as the world has become more aware of the advantages and necessity of cell line characterization technology, more money is being spent on R&D and product development.

Cell Line Characterization Market- Market Dynamics

Growing R&D in the Biotechnology and Pharmaceutical Sectors has Fueled the Growth of the Cell Line Characterization Market

The usage of cell line characterization is developing as a result of increased R&D in the biotechnology and pharmaceutical industries to address the growing need for treating a variety of chronic diseases. In order to better understand how cells interact with infectious agents like viruses and bacteria, researchers employ cells as model systems in their studies of cell chemistry and biology. In order to investigate how medications affect human cells, the cells are also employed in drug screening. Increased funding for medical research is driving the cell line characterization market growth. The growing R&D in the biotechnology and pharmaceutical industries has also contributed to the development of automated cell culture equipment. The cell line characterization business is expected to be propelled forward by this breakthrough. In the upcoming years, this will lead to the expansion of the pharmaceutical and biopharmaceutical industries, which will boost the global market for cell line characterization. Pharmaceutical, biotech, and other healthcare corporations are increasing their R&D spending, which is driving this expansion.

Cell Line Characterization Market- Key Insights

As per the analysis shared by our research analyst, the global Cell Line Characterization market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2024-2032).

Based on application segmentation, the cell line identity segment was predicted to show maximum market share in the year 2023.

Based on end-user segmentation, the academic and research institutes segment is expected to witness the fastest growth.

On the basis of region, North America was the leading revenue generator in 2023.

Cell Line Characterization Market- Segmentation Analysis:

The Global Cell Line Characterization Market is segmented on the basis of Cell Line Type, Application, End User, and Region.

The market is divided into two categories based on cell line type: Mammalian, Microbial, and Insect Cell. The mammalian category primarily led the market in 2023. The formation of the mammalian cell line is based on studies in gene and protein interaction and developmental biology. Due to their ease of adaptability to biological components and human tissues, as well as their decreased risk of infection, mammalian cell lines will drive market expansion over the projection period.

In addition, the market is segmented into four categories based on application: Cell Line Identity, Genetic Stability, Viral and Microbial Contamination, and Others. In 2023, the dominant segment within the market is the cell line identity category. In biopharmaceutical research and manufacturing, there is an increasing emphasis on guaranteeing the accuracy and dependability of cell line identities as regulatory authorities tighten their standards for cell line authentication and validation. The desire to reduce the hazards of cross-contamination, misidentification, and genetic drift-which can jeopardize study results, medication efficacy, and patient safety-has led to an increased emphasis on cell line identity verification.

Cell Line Characterization Market- Geographical Insights

The cell line characterization market exhibits geographical diversity across regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, each with its unique characteristics. North America, being a mature market, experiences high demand because of its strong biopharmaceutical sector and vast research network. Additionally, the further elements anticipated to grow the market are the development of technology, the rise of the market for biopharmaceuticals, and the growing range of uses for cell-based therapy and research.

Moreover, it is projected that the Asia Pacific market will grow over the forecast period, driven by a growing emphasis on the construction of healthcare infrastructure and growing capacity for the production of biopharmaceuticals. Additionally, the region is growing due to factors such as expanding investments in the biotechnology and pharmaceutical sectors, bettering healthcare infrastructure, and growing awareness of customized medicine.

Cell Line Characterization Market- Competitive Landscape:

Premas Biotechare, Thermo Fisher Scientific Inc., WuXi Biologics Cayman Inc., Promega Corp., DNA TwoPointO Inc., and others are a few of the prominent companies in the market. These players have engaged in multiple mergers and acquisitions as well as joint ventures to provide clients with cutting-edge products and solutions. In order to improve product capabilities and maintain market rivalry in the cell line characterization sector, these market players are putting various growth strategies, collaborations, launches, mergers, and acquisitions into practice.

Recent Developments:

November 2022: For the enteric (intestinal) distribution of drugs, Lonza unveiled a revolutionary new pill solution. While passing through the stomach, the Capsugel EnprotectTM capsule does not break down; it only releases its contents in the intestine. Manufacturing pharmaceutical products is facilitated by Capsugel EnprotectTM capsules, as they eliminate the need for further coating or sealing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL LINE CHARACTERIZATION MARKET KEY PLAYERS

  • Boehringer Ingelheim International GmbH
  • JSR Corp.
  • Premas Biotech
  • Danaher Corp.
  • DNA TwoPointO Inc.
  • MabPlex International Ltd.
  • Sartorius AG
  • Lonza Group Ltd.
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics Cayman Inc.
  • Promega Corp.
  • General Electric Co.
  • Corning Inc.
  • Others

GLOBAL CELL LINE CHARACTERIZATION MARKET, BY CELL LINE TYPE

  • Mammalian
  • Microbial
  • Insect Cell

GLOBAL CELL LINE CHARACTERIZATION MARKET, BY APPLICATION

  • Cell Line Identity
  • Genetic Stability
  • Viral and Microbial Contamination
  • Others

GLOBAL CELL LINE CHARACTERIZATION MARKET, BY END USER

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

GLOBAL CELL LINE CHARACTERIZATION MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Line Characterization Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Line Characterization Market Snippet by Cell Line Type
    • 2.1.2. Cell Line Characterization Market Snippet by Application
    • 2.1.3. Cell Line Characterization Market Snippet by End User
    • 2.1.4. Cell Line Characterization Market Snippet by Country
    • 2.1.5. Cell Line Characterization Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Line Characterization Key Market Trends

  • 3.1. Cell Line Characterization Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Line Characterization Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Line Characterization Market Opportunities
  • 3.4. Cell Line Characterization Market Future Trends

4. Cell Line Characterization Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Line Characterization Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell Line Characterization Market Landscape

  • 6.1. Cell Line Characterization Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Line Characterization Market - By Cell Line Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Cell Line Type, 2023 & 2032 (%)
    • 7.1.2. Mammalian
    • 7.1.3. Microbial
    • 7.1.4. Insect Cell

8. Cell Line Characterization Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Cell Line Identity
    • 8.1.3. Genetic Stability
    • 8.1.4. Viral and Microbial Contamination
    • 8.1.5. Others

9. Cell Line Characterization Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Academic and Research Institutes
    • 9.1.4. Others

10. Cell Line Characterization Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell Line Characterization Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell Line Characterization Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell Line Characterization Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cell Line Characterization Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cell Line Characterization Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Cell Line Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cell Line Characterization Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Boehringer Ingelheim International GmbH
    • 11.2.2. JSR Corp.
    • 11.2.3. Premas Biotech
    • 11.2.4. Danaher Corp.
    • 11.2.5. DNA TwoPointO Inc.
    • 11.2.6. MabPlex International Ltd.
    • 11.2.7. Sartorius AG
    • 11.2.8. Lonza Group Ltd.
    • 11.2.9. Thermo Fisher Scientific Inc.
    • 11.2.10. WuXi Biologics Cayman Inc.
    • 11.2.11. Promega Corp.
    • 11.2.12. General Electric Co.
    • 11.2.13. Corning Inc.
    • 11.2.14. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us